Aurora SpineASAPF 40 EV-to-FCF is 22.27 as of Jun. 24, 2026. GuruFocus rates ASAPF with a GF Score™ of 40/100 and a GF Value™ of $0.22 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 418 Medical Devices & Instruments companies, Aurora Spine ranks worse than 50.48% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Aurora Spine's Enterprise Value is $15.43 Mil.
Aurora Spine's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was $0.69 Mil. Therefore, Aurora Spine's EV-to-FCF for today is 22.27.
The historical rank and industry rank for Aurora Spine's EV-to-FCF or its related term are showing as below:
ASAPF'
s EV-to-FCF Range Over the Past 10 Years
Min: -358.15 Med: -5.4 Max: 736.39
Current: 22.27
During the past 13 years, the highest EV-to-FCF of Aurora Spine was 736.39. The lowest was -358.15. And the median was -5.40.
ASAPF's EV-to-FCF is ranked worse than 50.48% of 418
companies
in the Medical Devices & Instruments industry
Industry Median: 22.66
vs ASAPF: 22.27
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Aurora Spine's PE Ratio (TTM) for today is calculated as:
Aurora Spine's share price for today is $0.155.
Aurora Spine's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Aurora Spine EV-to-FCF Related Terms
Aurora Spine EV-to-FCF Historical Data
* Premium members only.
The historical data trend for Aurora Spine's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Aurora Spine's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Aurora Spine EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Aurora Spine's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Aurora Spine's EV-to-FCF falls into.
Aurora Spine's current Enterprise Value is $15.43 Mil.
Aurora Spine's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.69 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Aurora Spine (ASAPF) has a EV-to-FCF of 22.27 as of Jun. 24, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Aurora Spine and its competitors. According to the industry distribution chart, Aurora Spine ranks #211 out of 418 companies in the Medical Devices & Instruments industry, placing it in the top 50.5%.
Is Aurora Spine's EV-to-FCF too high?
Aurora Spine's current EV-to-FCF is 22.27. The Medical Devices & Instruments industry median EV-to-FCF is 22.66. Aurora Spine's value of 22.27 is 1.7% below this industry median. Based on the distribution chart, Aurora Spine ranks #211 out of 418 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Aurora Spine has a GF Score™ of 40/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Aurora Spine's EV-to-FCF compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Aurora Spine ranks #211 out of 418 companies for EV-to-FCF. This places Aurora Spine in the lower half of its industry. The industry median EV-to-FCF is 22.66. Aurora Spine's value of 22.27 is 1.7% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 22.66, based on 418 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Aurora Spine's current EV-to-FCF of 22.27 is 1.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on Aurora Spine and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 22.66 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Aurora Spine's current EV-to-FCF is 22.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aurora Spine stock overvalued right now?
Based on GuruFocus' analysis, Aurora Spine (ASAPF) is currently considered Possible Value Trap. The stock's GF Value™ is $0.22, compared to a current price of $0.16 — trading 29.5% below its estimated fair value. The current EV-to-FCF is 22.27 and 1.7% below the Medical Devices & Instruments industry median of 22.66. Aurora Spine's overall GF Score™ is 40/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For Aurora Spine (ASAPF), the current EV-to-FCF is 22.27 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Aurora Spine (ASAPF) Overvalued in 2026?
Based on GuruFocus' analysis, Aurora Spine stock appears to be undervalued.
The current stock price of $0.16 is trading 29.5% below its estimated GF Value™ of $0.22.
GuruFocus considers Aurora Spine to be Possible Value Trap.
Key valuation signals for ASAPF:
EV-to-FCF: 22.27
GF Value™: $0.22 vs. price of $0.16 (29.5% below fair value)
Industry Position: 1.7% below the Medical Devices & Instruments median (#211 of 418)
No single metric tells the full story. See the ASAPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Aurora Spine Corp is engaged in the development, manufacture, and sale of minimally invasive, interspinous fusion systems and devices. These 510K and patent protected medical devices improve patient outcomes in the area of spine and sacroiliac joint surgical procedures. The company is focused on bringing new solutions to the spinal implant market through a series of minimally invasive, regenerative spinal implant technologies.
40GF Score
Get the complete analysis for ASAPF
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ASAPF has been successfully added to your 
